JP2014524888A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524888A5
JP2014524888A5 JP2014511830A JP2014511830A JP2014524888A5 JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5 JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
substituted
precatalyst
disproportionated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524888A (ja
JP5925301B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/059344 external-priority patent/WO2012160015A1/en
Publication of JP2014524888A publication Critical patent/JP2014524888A/ja
Publication of JP2014524888A5 publication Critical patent/JP2014524888A5/ja
Application granted granted Critical
Publication of JP5925301B2 publication Critical patent/JP5925301B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511830A 2011-05-23 2012-05-21 N−アルキル基を含有するジュウテリウム化化合物の製造方法 Expired - Fee Related JP5925301B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11305634.5 2011-05-23
EP11305634 2011-05-23
PCT/EP2012/059344 WO2012160015A1 (en) 2011-05-23 2012-05-21 Process for the preparation of deuterated compounds containing n-alkyl groups

Publications (3)

Publication Number Publication Date
JP2014524888A JP2014524888A (ja) 2014-09-25
JP2014524888A5 true JP2014524888A5 (enExample) 2015-07-02
JP5925301B2 JP5925301B2 (ja) 2016-05-25

Family

ID=46146876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511830A Expired - Fee Related JP5925301B2 (ja) 2011-05-23 2012-05-21 N−アルキル基を含有するジュウテリウム化化合物の製造方法

Country Status (10)

Country Link
US (1) US9340489B2 (enExample)
EP (1) EP2714624B1 (enExample)
JP (1) JP5925301B2 (enExample)
KR (1) KR20140030267A (enExample)
CN (1) CN103702961A (enExample)
CA (1) CA2834920A1 (enExample)
IL (1) IL229037A0 (enExample)
RU (1) RU2013156864A (enExample)
SG (1) SG194625A1 (enExample)
WO (1) WO2012160015A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20170664A1 (es) 2014-06-06 2017-06-10 Res Triangle Inst Agonistas del receptor de apelina(apj) y usos de los mismos
CA2967316C (en) * 2014-11-10 2021-12-14 Forge Life Science, Llc Anti-hcmv compositions and methods
PE20190258A1 (es) 2015-12-09 2019-02-25 Res Triangle Inst Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos
MX384332B (es) 2016-09-16 2025-03-14 Res Triangle Inst Antagonistas opioides kappa de tetrahidroisoquinolina.
PE20190806A1 (es) 2016-10-12 2019-06-10 Res Triangle Inst Agonistas heterociclicos del receptor de apelina (apj) y usos de los mismos
JOP20190072A1 (ar) 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم
US10696677B2 (en) 2016-12-21 2020-06-30 Research Triangle Institute Diaryl purine derivatives with improved bioavailability
JP7064507B2 (ja) * 2017-04-27 2022-05-10 デューテリア ビバレッジズ、エルエルシー D2oからの重水素化エタノールの調製方法
EA039766B1 (ru) 2017-04-27 2022-03-11 Дьютерия Бевериджес, Ллс Способ получения дейтерированного этанола из d2
SG11202001684PA (en) 2017-10-06 2020-03-30 Forma Therapeutics Inc Inhibiting ubiquitin specific peptidase 30
CN109748767A (zh) * 2017-11-07 2019-05-14 朱允涛 一种利用微波反应装置制备氘代胺类化合物的方法
ES2988920T3 (es) 2018-05-17 2024-11-22 Forma Therapeutics Inc Compuestos bicíclicos fusionados útiles como inhibidores de la peptidasa 30 específica de ubiquitina
WO2020041344A1 (en) 2018-08-20 2020-02-27 Duke University Methods and compositions for drugs to treat ophthalmic diseases
PL3860989T3 (pl) 2018-10-05 2023-07-10 Forma Therapeutics, Inc. Sprzężone piroliny, które działają jako inhibitory proteazy 30 swoistej dla ubikwityny (usp30)
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
JP7548906B2 (ja) * 2018-12-21 2024-09-10 テラン バイオサイエンシズ インコーポレイテッド ボリナンセリンの重水素化形態および誘導体
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
CR20230325A (es) 2020-12-30 2023-12-11 Tyra Biosciences Inc Compuestos de indazol como inhibidores de cinasas
JP2024507574A (ja) 2021-02-25 2024-02-20 リサーチ トライアングル インスティテュート アペリン受容体アゴニストとしてのヘテロアリール誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0335918A1 (en) 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
AU652759B2 (en) 1990-06-01 1994-09-08 Aventisub Ii Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
EP1688412A3 (en) 2001-02-16 2006-08-16 Aventis Pharmaceuticals, Inc. Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
TW200413274A (en) * 2002-12-27 2004-08-01 Wako Pure Chem Ind Ltd Deuteration or tritiation method
WO2005070853A1 (ja) * 2004-01-23 2005-08-04 Wako Pure Chemical Industries, Ltd. 混合触媒を用いた重水素化方法
WO2008122010A1 (en) * 2007-04-02 2008-10-09 Concert Pharmaceuticals, Inc. Pharmaceutical calcimimetics
WO2009005069A1 (ja) 2007-07-05 2009-01-08 Wako Pure Chemical Industries, Ltd. ルテニウム触媒を用いた重水素化方法
US20100143287A1 (en) * 2008-12-09 2010-06-10 Auspex Pharmaceuticals, Inc. Trifluoromethylphenyl modulators of calcium-sensing receptor

Similar Documents

Publication Publication Date Title
JP2013040159A5 (ja) 有機金属錯体
JP2013147496A5 (ja) 有機金属錯体
JP2014029971A5 (ja) 有機化合物
JP2013102146A5 (ja) 化合物
JP2015042636A5 (ja) 有機化合物
JP2012140458A5 (enExample)
JP2013010752A5 (ja) 有機金属錯体
JP2012149030A5 (ja) 化合物
JP2013126982A5 (ja) 有機金属錯体及び発光材料
JP2012248871A5 (ja) 発光素子および発光装置
JP2012092103A5 (enExample)
JP2010241801A5 (enExample)
JP2015522045A5 (enExample)
JP2012006912A5 (ja) トリアゾール誘導体
JP2013100341A5 (enExample)
JP2011121940A5 (ja) 発光素子
JP2009535462A5 (enExample)
JP2010189376A5 (ja) 有機金属錯体
JP2013010096A5 (enExample)
JP2015078176A5 (enExample)
JP2012140436A5 (ja) 物質
JP2012107003A5 (ja) 有機金属錯体
JP2013147490A5 (ja) イリジウム錯体
JP2013063963A5 (ja) 複素環化合物
JP2013010731A5 (ja) 複素環化合物